공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 의약품 연속 생산 시장 : 제품, 용도, 최종사용자별 기회 분석과 산업 예측(2019-2026년)

Pharmaceutical Continuous Manufacturing Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026

리서치사 Allied Market Research
발행일 2019년 12월 상품 코드 923971
페이지 정보 영문 245 Pages
가격
US $ 3,840 ₩ 4,264,000 Excel (Data Pack) help
DRM(디지털 저작권 관리 시스템) 장착 Excel 파일로, 1명만 이용할 수 있는 라이선스입니다. 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 Excel파일 라이선스 소유자로 한정됩니다.
US $ 5,769 ₩ 6,407,000 PDF (Single User License + Covid impact) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste 가 되지 않으며, 인쇄는 1회에 한해 가능합니다. 인쇄물 이용은 PDF 라이선스 소유자로 한정됩니다.
US $ 6,450 ₩ 7,163,000 PDF (5-user License) help
DRM(디지털 저작권 관리 시스템) 장착 PDF 파일로, 5명까지 이용할 수 있는 라이선스입니다. 인쇄는 5회까지 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,995 ₩ 9,989,000 PDF (Enterprise User License) help
동일 기업 내의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 본 보고서는 DRM(디지털 저작권 관리 시스템)이 장착된 PDF 파일로, 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 의약품 연속 생산 시장 : 제품, 용도, 최종사용자별 기회 분석과 산업 예측(2019-2026년) Pharmaceutical Continuous Manufacturing Market by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026
발행일 : 2019년 12월 페이지 정보 : 영문 245 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 의약품 연속 생산 시장은 2018년에 3억 9,300만 달러를 기록했으며, 2019-2026년간 10.2%의 CAGR로 확대되어 2026년까지 8억 5,500만 달러 규모 시장으로 성장할 것으로 예측됩니다. 기존의 의약품 생산 공정에서 의약품 연속 생산으로의 이동, 연속 생산 시스템의 기술적 진보, 개발도상국에서의 연속 생산 시스템 인지도 향상, 생산량 변동 축소, 수율 개선, 운용 비용 절감 등의 요인이 시장 성장을 촉진할 전망입니다.

세계의 의약품 연속 생산(Pharmaceutical Continuous Manufacturing) 시장을 조사했으며, 시장 개요, 제품·용도·최종사용자·지역별 시장 규모 추정과 예측, 시장 성장 촉진요인 및 저해요인 분석, 시장 기회, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

  • 보고서 개요
  • 이해관계자의 주요 이점
  • 주요 시장 부문
  • 조사 방법

제2장 주요 요약

제3장 시장 개요

  • 시장 정의와 범위
  • 주요 조사 결과
  • 시장 역학
    • 성장 촉진요인
    • 성장 저해요인
    • 시장 기회
    • 영향요인 분석

제4장 세계의 의약품 연속 생산 시장 : 제품별

  • 개요
    • 시장 규모와 예측
  • 통합 연속 시스템
    • 주요 시장 동향과 기회
    • 시장 규모와 예측 : 지역별
    • 시장 분석 : 국가별
  • 반연속 시스템
  • 제어와 소프트웨어

제5장 세계의 의약품 연속 생산 시장 : 용도별

  • 개요
    • 시장 규모와 예측
  • 최종 제품
  • 원료의약품(API) 제조
    • 시장 규모와 예측
    • 시장 분석 : 국가별

제6장 세계의 의약품 연속 생산 시장 : 최종사용자별

  • 개요
    • 시장 규모와 예측
  • 제약 기업
    • 시장 규모와 예측
    • 시장 분석 : 국가별
  • CRO
  • 기타

제7장 세계의 의약품 연속 생산 시장 : 지역별

  • 개요
    • 시장 규모와 예측
  • 북미
    • 주요 시장 동향, 성장 촉진요인, 시장 기회
    • 시장 규모와 예측 : 국가별
    • 북미의 시장 규모와 예측 : 제품별
    • 북미의 시장 규모와 예측 : 용도별
    • 북미의 시장 규모와 예측 : 최종사용자별
  • 유럽
  • 아시아태평양
  • 라틴아메리카, 중동 및 아프리카

제8장 기업 개요

  • Coperion Gmbh
  • Gea Group Ag
  • Gebruder Lodige Maschinenbau Gmbh
  • Glatt Gmbh
  • Hosokawa Micron Corporation
  • Korsch Ag
  • L.B. Bohle Maschinen + Verfahren Gmbh
  • Munson Machinery Company, Inc.
  • Robert Bosch Packaging Technology Gmbh
  • Thermo Fisher Scientific, Inc.
KSM 20.02.26

List of Tables

Table 01. Global Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026 ($Million)

Table 02. Integrated Continuous Systems Market, By Region, 2018-2026 ($Million)

Table 03. Semi-Continuous Systems Market, By Region, 2018-2026 ($Million)

Table 04. Others Market, By Region, 2018-2026 ($Million)

Table 05. Global Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026 ($Million)

Table 06. Final Drug Product Manufacturing Market, By Region, 2018-2026 ($Million)

Table 07. Api Manufacturing Market, By Region, 2018-2026 ($Million)

Table 08. Global Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026 ($Million)

Table 09. Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Region, 2018-2026 ($Million)

Table 10. Pharmaceutical Continuous Manufacturing For Contract Manufacturing Organizations, By Region, 2018-2026 ($Million)

Table 11. Pharmaceutical Continuous Manufacturing For Others, By Region, 2018-2026 ($Million)

Table 12. Pharmaceutical Continuous Manufacturing Market Revenue, By Region, 2018-2026 ($Million)

Table 13. North America Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)

Table 14. U.S. Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 15. U.S. Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 16. U.S. Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 17. Canada Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 18. Canada Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 19. Canada Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 20. Mexico Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 21. Mexico Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 22. Mexico Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 23. North America Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 24. North America Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 25. North America Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 26. Europe Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)

Table 27. Germany Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 28. Germany Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 29. Germany Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 30. France Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 31. France Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 32. France Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 33. Uk Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 34. Uk Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 35. Uk Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 36. Italy Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 37. Italy Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 38. Italy Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 39. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 40. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 41. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 42. Europe Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 43. Europe Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 44. Europe Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 45. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)

Table 46. Japan Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 47. Japan Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 48. Japan Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 49. China Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 50. China Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 51. China Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 52. India Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 53. India Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 54. India Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 55. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 56. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 57. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 58. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 59. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 60. Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 61. Lamea Pharmaceutical Continuous Manufacturing Market, By Country, 2018-2026 ($Million)

Table 62. Brazil Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 63. Brazil Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 64. Brazil Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 65. South Africa Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 66. South Africa Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 67. South Africa Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 68. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 69. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 70. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 71. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 72. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 73. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 74. Lamea Pharmaceutical Continuous Manufacturing Market, By Product, 2018-2026

Table 75. Lamea Pharmaceutical Continuous Manufacturing Market, By Application, 2018-2026

Table 76. Lamea Pharmaceutical Continuous Manufacturing Market, By End User, 2018-2026

Table 77. Coperion: Company Snapshot

Table 78. Coperion: Business Segment

Table 79. Gea Group: Company Snapshot

Table 80. Gea Group: Operating Segments

Table 81. Gea Group: Product Portfolio

Table 82. Lodige: Company Snapshot

Table 83. Lodige: Operating Segments

Table 84. Lodige: Product Portfolio

Table 85. Glatt: Company Snapshot

Table 86. Glatt: Operating Segments

Table 87. Glatt: Product Portfolio

Table 88. Hosokawa: Company Snapshot

Table 89. Hosokawa: Product Portfolio

Table 90. Korsch: Company Snapshot

Table 91. Korsch: Operating Segments

Table 92. Korsch: Product Portfolio

Table 93. L.B. Bohle: Company Snapshot

Table 94. L.B. Bohle: Operating Segments

Table 95. Munson: Company Snapshot

Table 96. L.B. Bohle: Operating Product Segments

Table 97. Munson: Product Portfolio

Table 98. Bosch Group: Company Snapshot

Table 99. Bosch Group: Operating Segments

Table 100. Bosch Group: Product Portfolio

Table 101. Thermo Fisher Scientific: Company Snapshot

Table 102. Thermo Fisher Scientific: Operating Segments

Table 103. Thermo Fisher Scientific: Product Portfolio

List of Figures

Figure 01. Global Pharmaceutical Continuous Manufacturing Market Segmentation

Figure 02. Top Investment Pockets, 2018

Figure 03. Market Player Positioning, 2018

Figure 04. Impact Analysis

Figure 05. Comparative Analysis of Integrated Continuous Systems Market, By Country, 2018 & 2026 ($Million)

Figure 06. Comparative Analysis of Semi-Continuous Systems Market, By Country, 2018 & 2026 ($Million)

Figure 07. Comparative Analysis of Control & Software Market, By Country, 2018 & 2026 ($Million)

Figure 08. Comparative Analysis of Final Drug Product Manufacturing Market, By Country, 2018 & 2026 ($Million)

Figure 09. Comparative Analysis of Api Manufacturing Market, By Country, 2018 & 2026 ($Million)

Figure 10. Comparative Analysis of Pharmaceutical Continuous Manufacturing For Pharmaceutical Companies Market, By Country, 2018 & 2026 ($Million)

Figure 11. Comparative Analysis Pharmaceutical Continuous Manufacturing Market For Contract Manufacturing Organizations, By Country, 2018 & 2026 (%)

Figure 12. Comparative Analysis of Pharmaceutical Continuous Manufacturing Market For Others, By Country, 2018 & 2026 (%)

Figure 13. Net Sales, 2016-2018 ($Million)

Figure 14. Gea Group: Net Sales By Segment, 2018 (%)

Figure 15. Gea Group: Net Sales By Region, 2018 (%)

Figure 16. Net Sales, 2016-2018 ($Million)

Figure 17. Hosokawa: Net Sales By Segment, 2018 (%)

Figure 18. Hosokawa: Net Sales By Geography, 2018 (%)

Figure 19. Net Sales, 2016-2018 ($Million)

Figure 20. Bosch Group: Net Sales By Segment, 2018 (%)

Figure 21. Bosch Group: Net Sales By Revenue, 2018 (%)

Figure 22. Thermo Fisher Scientific: Revenue, 2016-2018 ($Million)

Figure 23. Thermo Fisher Scientific: Revenue Share, By Segment, 2018 (%)

Figure 24. Thermo Fisher Scientific: Revenue Share, By Region, 2018 (%)

The global pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is projected to reach $855 million by 2026, registering a CAGR of 10.2% from 2019 to 2026.

Continuous manufacturing is advanced manufacturing approach that is performed by employing end-to-end integration of manufacturing subprocesses with a significant level of control strategies.

The growth of the global pharmaceutical continuous manufacturing market is anticipated to be driven by increase in adoption of continuous manufacturing systems over existing drug manufacturing process, technological advancements in CM systems, and rise in awareness of continuous manufacturing systems in developing regions are anticipated to significantly boost the growth of the pharmaceutical continuous manufacturing market during the forecast period. Continuous pharmaceutical manufacturing system offers advantages such as reduced fluctuation in production, improved yields, lower cost of operation & equipment further augment the market growth.

Moreover, initiatives taken by the Food and drug Administration (FDA) for promoting the use of pharmaceutical continuous manufacturing systems and advantage of CM systems over the batch manufacturing are the major factors to boost the growth of pharmaceutical continuous manufacturing market. However, higher cost of pharmaceutical continuous manufacturing systems impede the market growth.

Moreover, the CM process is more time-efficient, reduces energy needs, helps to increase productivity, and minimizes overall waste, which are expected to offer lucrative opportunity for the pharmaceutical continuous manufacturing market during the forecast period.

The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and region. On the basis of product, the market is classified into integrated continuous systems, semicontinuous systems, and control & software. By application, it is divided into final drug product manufacturing and API manufacturing. Depending on end user, it is categorized into pharmaceutical companies, contract manufacturing organizations, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.

It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.

A comprehensive analysis of four major regions is provided to determine the existing opportunities.

The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product

  • Integrated Continuous Systems
  • Semicontinuous Systems
  • Control & Software
  • Application Type
  • Final Drug Product Manufacturing
  • API Manufacturing
  • End User
  • Pharmaceutical Companies
  • Contract Manufacturing Organizations
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Bosch Packaging Technology
  • Coperion GmbH
  • GEA Group AG
  • Gebruder Lodige Maschinenbau GmbH
  • Glatt GmbH
  • Hosokawa Micron Corporation
  • Korsch AG
  • L.B. Bohle Maschinen + Verfahren GmbH
  • Munson Machinery Company, Inc.
  • Thermo Fisher Scientific Inc.

Table of Contents

Chapter 1: Introduction

  • 1.1. Report Description
  • 1.2. Key Benefits For Stakeholders
  • 1.3. Key Market Segments
    • 1.3.1. List of Key Players Profiled In The Report
  • 1.4. Research Methodology
    • 1.4.1. Secondary Research
    • 1.4.2. Primary Research
    • 1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

  • 2.1. Key Findings of The Study
  • 2.2. Cxo Perspective

Chapter 3: Market Overview

  • 3.1. Market Definition And Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Market Player Positioning, 2018
  • 3.3. Market Dynamics
    • 3.3.1. Drivers
      • 3.3.1.1. Increase In Government Support For Continuous Manufacturing Adoption
      • 3.3.1.2. Advantages offered By Continuous Manufacturing Systems
      • 3.3.1.3. Surge In Adoption of Pharmaceutical Continuous Manufacturing Systems
    • 3.3.2. Restraint
      • 3.3.2.1. Poor Demand In Under Developed Countries
    • 3.3.3. Opportunities
      • 3.3.3.1. Growth Opportunities In Emerging Markets
    • 3.3.4. Impact Analysis

Chapter 4: Pharmaceutical Continuous Manufacturing Market, By Product

  • 4.1. Overview
    • 4.1.1. Market Size And Forecast
  • 4.2. Integrated Continuous Systems
    • 4.2.1. Key Market Trends And Opportunities
    • 4.2.2. Market Size And Forecast, By Region
    • 4.2.3. Market Analysis, By Country
  • 4.3. Semi-Continuous Systems
    • 4.3.1. Key Market Trends And Opportunities
    • 4.3.2. Market Size And Forecast, By Region
    • 4.3.3. Market Analysis, By Country
  • 4.4. Control & Software
    • 4.4.1. Key Market Trends And Opportunities
    • 4.4.2. Market Size And Forecast, By Region
    • 4.4.3. Market Analysis, By Country

Chapter 5: Pharmaceutical Continuous Manufacturing Market, By Application

  • 5.1. Overview
    • 5.1.1. Market Size And Forecast
  • 5.2. Final Drug Product Manufacturing
    • 5.2.1. Market Size And Forecast
    • 5.2.2. Market Analysis, By Country
  • 5.3. Api Manufacturing
    • 5.3.1. Market Size And Forecast
    • 5.3.2. Market Analysis, By Country

Chapter 6: Pharmaceutical Continuous Manufacturing Market, By End User

  • 6.1. Overview
    • 6.1.1. Market Size And Forecast
  • 6.2. Pharmaceutical Companies
    • 6.2.1. Market Size And Forecast
    • 6.2.2. Market Analysis, By Country
  • 6.3. Contract Manufacturing Organizations
    • 6.3.1. Market Size And Forecast
    • 6.3.2. Market Analysis, By Country
  • 6.4. Others
    • 6.4.1. Market Size And Forecast
    • 6.4.2. Market Analysis, By Country

Chapter 7: Pharmaceutical Continuous Manufacturing Market, By Region

  • 7.1. Overview
    • 7.1.1. Market Size And Forecast
  • 7.2. North America
    • 7.2.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.2.2. Market Size And Forecast, By Country
      • 7.2.2.1. U.S.
      • 7.2.2.1.1. U.S. Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.2.2.1.2. U.S. Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.2.2.1.3. U.S. Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.2.2.2. Canada
      • 7.2.2.2.1. Canada Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.2.2.2.2. Canada Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.2.2.2.3. Canada Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.2.2.3. Mexico
      • 7.2.2.3.1. Mexico Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.2.2.3.2. Mexico Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.2.2.3.3. Mexico Pharmaceutical Continuous Manufacturing Market, By End User
    • 7.2.3. North America Market Size And Forecast, By Product
    • 7.2.4. North America Market Size And Forecast, By Application
    • 7.2.5. North America Market Size And Forecast, By End User
  • 7.3. Europe
    • 7.3.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.3.2. Market Size And Forecast, By Country
      • 7.3.2.1. Germany
      • 7.3.2.1.1. Germany Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.1.2. Germany Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.1.3. Germany Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.3.2.2. France
      • 7.3.2.2.1. France Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.2.2. France Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.2.3. France Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.3.2.3. Uk
      • 7.3.2.3.1. Uk Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.3.2. Uk Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.3.3. Uk Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.3.2.4. Italy
      • 7.3.2.4.1. Italy Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.4.2. Italy Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.4.3. Italy Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.3.2.5. Rest of Europe
      • 7.3.2.5.1. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.3.2.5.2. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.3.2.5.3. Rest of Europe Pharmaceutical Continuous Manufacturing Market, By End User
    • 7.3.3. Europe Market Size And Forecast, By Product
    • 7.3.4. Europe Market Size And Forecast, By Application
    • 7.3.5. Europe Market Size And Forecast, By End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.4.2. Market Size And Forecast, By Country
      • 7.4.2.1. Japan
      • 7.4.2.1.1. Japan Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.4.2.1.2. Japan Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.4.2.1.3. Japan Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.4.2.2. China
      • 7.4.2.2.1. China Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.4.2.2.2. China Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.4.2.2.3. China Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.4.2.3. India
      • 7.4.2.3.1. India Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.4.2.3.2. India Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.4.2.3.3. India Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.4.2.4. Rest of Asia-Pacific
      • 7.4.2.4.1. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.4.2.4.2. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.4.2.4.3. Rest of Asia-Pacific Pharmaceutical Continuous Manufacturing Market, By End User
    • 7.4.3. Asia-Pacific Market Size And Forecast, By Product
    • 7.4.4. Asia-Pacific Market Size And Forecast, By Application
    • 7.4.5. Asia-Pacific Market Size And Forecast, By End User
  • 7.5. Lamea
    • 7.5.1. Key Market Trends, Growth Factors, And Opportunities
    • 7.5.2. Market Size And Forecast, By Country
      • 7.5.2.1. Brazil
      • 7.5.2.1.1. Brazil Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.5.2.1.2. Brazil Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.5.2.1.3. Brazil Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.5.2.2. South Africa
      • 7.5.2.2.1. South Africa Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.5.2.2.2. South Africa Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.5.2.2.3. South Africa Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.5.2.3. Saudi Arabia
      • 7.5.2.3.1. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.5.2.3.2. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.5.2.3.3. Saudi Arabia Pharmaceutical Continuous Manufacturing Market, By End User
      • 7.5.2.4. Rest of Lamea
      • 7.5.2.4.1. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Product
      • 7.5.2.4.2. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By Application
      • 7.5.2.4.3. Rest of Lamea Pharmaceutical Continuous Manufacturing Market, By End User
    • 7.5.3. Lamea Market Size And Forecast, By Product
    • 7.5.4. Lamea Market Size And Forecast, By Application
    • 7.5.5. Lamea Market Size And Forecast, By End User

Chapter 8: Company Profiles

  • 8.1. Coperion Gmbh
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Operating Business Segments
    • 8.1.4. Product Portfolio
    • 8.1.5. Key Strategic Moves And Developments
  • 8.2. Gea Group Ag
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Operating Business Segments
    • 8.2.4. Product Portfolio
    • 8.2.5. Business Performance
  • 8.3. Gebruder Lodige Maschinenbau Gmbh
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Operating Business Segments
    • 8.3.4. Product Portfolio
  • 8.4. Glatt Gmbh
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Operating Business Segments
    • 8.4.4. Product Portfolio
  • 8.5. Hosokawa Micron Corporation
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Product Portfolio
    • 8.5.4. Business Performance
  • 8.6. Korsch Ag
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Operating Business Segments
    • 8.6.4. Product Portfolio
  • 8.7. L.B. Bohle Maschinen + Verfahren Gmbh
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Operating Business Segments
    • 8.7.4. Product Portfolio
  • 8.8. Munson Machinery Company, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Operating Business Segments
    • 8.8.4. Product Portfolio
  • 8.9. Robert Bosch Packaging Technology Gmbh
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Operating Business Segments
    • 8.9.4. Product Portfolio
    • 8.9.5. Business Performance
  • 8.10. Thermo Fisher Scientific, Inc.
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Operating Business Segments
    • 8.10.4. Product Portfolio
    • 8.10.5. Business Performance
Back to Top
전화 문의
F A Q